Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. - Related Studies

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.

This study has been completed.

Study NCT00036218. Last updated on June 6, 2006. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Parkinson Disease

2	More general conditions related to this trial
		Basal Ganglia Diseases
		Brain Diseases
		Central Nervous System Diseases
		Movement Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Parkinsonian Disorders

3	Interventions listed in this trial
		sumanirole
		ropinirole

4	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Antiparkinson Agents
		Central Nervous System Agents
		Dopamine Agents
		Dopamine Agonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

5	Sponsors listed in this trial
		Pfizer